Company Name, Ticker, Customers, else..

Icosavax Inc (NASDAQ: ICVX)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Icosavax Inc 's

Name: Icosavax Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ICVX Sales vs. its Competitors Q3 2023

Comparing the current results to its competitors, Icosavax Inc reported Revenue decrease in the 3 quarter 2023 year on year by 0 %, slower than the combined decrease of the ICVX's competitors by -41.96 %, recorded in the same quarter.

• List of ICVX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Icosavax Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< ICVX Stock Performance Comparisons

<< See the full list of ICVX competitors

*Market share is calculated based on total revenue.

ICVX's Stock Performance relative to its Competitors

Publicly Traded Peers of Icosavax Inc

Biontech Se
Share Performance

-12.95%

30 Days

Biontech Se

Profile

Biontech SE's business model focuses on the development and commercialization of novel mRNA-based immunotherapies for various diseases, including cancer.

More about Biontech Se's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 3,214.288 mill.	$ -1,272.432 mill.

Grace Therapeutics Inc
Share Performance

-11.36%

This Quarter

Grace Therapeutics Inc

Profile

The company develops drug delivery formulations for rare and orphan diseases.

More about Grace Therapeutics Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 36.281 mill.	$ - mill.	$ -20.221 mill.

Gsk Plc
Share Performance

-5.13%

This Quarter

Gsk Plc

Profile

Glaxosmithkline Plc's business model focuses on researching, developing, manufacturing, and marketing innovative healthcare products and medicines globally.

More about Gsk Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 43,093.888 mill.	$ 8,296.368 mill.

Immunitybio inc
Share Performance

+313.61%

This Year

Immunitybio inc

Profile

Immunitybio Inc operates on a business model that focuses on developing and commercializing innovative immunotherapies and vaccines to address various diseases and medical conditions. They aim to use their broad scientific expertise, technology platforms, and strategic partnerships to advance their products and improve patient outcomes in healthcare.

More about Immunitybio inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 8,773.335 mill.	$ 165.792 mill.	$ -992.419 mill.

Invivyd Inc
Share Performance

-15.17%

One Year

Invivyd Inc

Profile

Invivyd Inc is a company that operates on a particular business model to deliver its products or services, but without providing any further details.

More about Invivyd Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 304.445 mill.	$ 58.365 mill.	$ -107.333 mill.

27 more competitors available

Sources: Icosavax Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 7:42 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Icosavax Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.